V
LLY icon

VeraBank’s Eli Lilly LLY Stock Holding History

VeraBank’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Sell
2,632
-136
-5% -$139K 0.52% 32
2026
Q1 		$2.55M Sell
2,768
-250
-8% -$253K 0.47% 33
2025
Q4 		$3.24M Sell
3,018
-71
-2% -$67.9K 0.59% 27
2025
Q3 		$2.36M Hold
3,089
– – 0.44% 41
2025
Q2 		$2.41M Buy
3,089
+150
+5% +$117K 0.48% 39
2025
Q1 		$2.43M Sell
2,939
-750
-20% -$624K 0.68% 29
2024
Q4 		$2.85M Buy
3,689
+23
+0.6% +$19K 0.8% 26
2024
Q3 		$3.25M Sell
3,666
-3
-0.1% -$2.7K 0.95% 22
2024
Q2 		$3.32M Sell
3,669
-10
-0.3% -$8K 1.03% 22
2024
Q1 		$2.86M Sell
3,679
-146
-4% -$104K 0.89% 25
2023
Q4 		$2.23M Buy
3,825
+78
+2% +$45.5K 0.75% 30
2023
Q3 		$2.01M Buy
3,747
+70
+2% +$36.1K 0.77% 29
2023
Q2 		$1.72M Hold
3,677
– – 0.66% 40
2023
Q1 		$1.26M Sell
3,677
-32
-0.9% -$10.8K 0.59% 44
2022
Q4 		$1.36M Hold
3,709
– – 0.68% 37
2022
Q3 		$1.2M Hold
3,709
– – 0.76% 36
2022
Q2 		$1.2M Sell
3,709
-34
-0.9% -$10.2K 0.7% 38
2022
Q1 		$1.07M Sell
3,743
-39
-1% -$10K 0.55% 44
2021
Q4 		$1.04M Buy
3,782
+236
+7% +$59.8K 0.53% 45
2021
Q3 		$819K Buy
3,546
+88
+3% +$21.7K 0.46% 53
2021
Q2 		$794K Buy
3,458
+58
+2% +$11.7K 0.47% 48
2021
Q1 		$635K Hold
3,400
– – 0.41% 58
2020
Q4 		$574K Hold
3,400
– – 0.4% 60
2020
Q3 		$503K Hold
3,400
– – 0.39% 61
2020
Q2 		$558K Hold
3,400
– – 0.46% 54
2020
Q1 		$472K Buy
3,400
+1,500
+79% +$206K 0.46% 56
2019
Q4 		$250K Buy
+1,900
New +$220K 0.2% 91

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VeraBank's LLY Position: Q2 2026 in Review

VeraBank reduced its Eli Lilly (LLY) stake by 4.9% in Q2 2026, selling an estimated $139K and leaving 2,632 shares worth $3.16M. The position accounts for 0.52% of the portfolio, ranked #32.

VeraBank first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.32M in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • VeraBank held 2,632 shares of Eli Lilly worth $3.16M as of Q2 2026.
  • VeraBank sold 136 Eli Lilly shares in Q2 2026, an estimated $139K.
  • Eli Lilly made up 0.52% of VeraBank's portfolio in Q2 2026, its #32 holding.
  • VeraBank first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • VeraBank's Eli Lilly position peaked at $3.32M in Q2 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on VeraBank's 13F filing for Q2 2026, filed 6 Aug 2026.